Patents by Inventor Kevin Gillman

Kevin Gillman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NK-1 AND SEROTONIN TRANSPORTER INHIBITORS
    Publication number: 20070249607
    Abstract: The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both.
    Type: Application
    Filed: April 13, 2007
    Publication date: October 25, 2007
    Inventors: Andrew Degnan, Kevin Gillman, Derek Denhart, Jonathan Ditta, Ramkumar Rajamani, Ying Han, George Tora
  • 4-Arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
    Publication number: 20060063790
    Abstract: The invention encompasses compounds of Formula I, which are blockers of KCNQ channels. Blockers of KCNQ channels are known to enchance cognition in laboratory animals. The invention includes, salts, solvates, compositions, and methods of use.
    Type: Application
    Filed: September 8, 2005
    Publication date: March 23, 2006
    Inventors: Kevin Gillman, Dharmpal Dodd, John Starrett, Danielle Bocchino
  • Carbohydrate prodrugs of fluorooxindoles
    Patent number: 6916937
    Abstract: The present invention provides novel prodrug derivatives of fluorooxindoles having the general Formula I wherein the wavy bond () represents the racemate, the (R)-enantiomer or the (S)-enantiomer, and R1, R2, R3, R4 and X are as defined herein, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: July 12, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kevin Gillman, Danielle M. Bocchino
  • Carbohydrate prodrugs of fluorooxindoles
    Publication number: 20040152646
    Abstract: The present invention provides novel prodrug derivatives of fluorooxindoles having the general Formula I 1
    Type: Application
    Filed: January 22, 2004
    Publication date: August 5, 2004
    Inventors: Kevin Gillman, Danielle M. Bocchino
  • Imidazolone anorectic agents: III. heteroaryl derivatives
    Patent number: 6096745
    Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of heteroaryl derivatives of imidazolone compounds of Formula 1. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: August 1, 2000
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Graham S. Poindexter, Kevin Gillman
  • Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-diphenyl-4H-imidazol-4-ones
    Patent number: 6063934
    Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of acyclic derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: May 16, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: Graham S. Poindexter, Kevin Gillman
  • Imidazolone anorectic agents: II. phenyl derivatives
    Patent number: 6054590
    Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of phenyl derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: April 25, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: Graham S. Poindexter, Ildiko Antal, Leah M. Giupponi, Robert H. Stoffel, Kevin Gillman, Mendi Higgins